NCT03920358View on ClinicalTrials.gov

FRED/ FRED Jr/ FRED X Intracranial Aneurysm Treatment Study

Active, not recruitingOBSERVATIONAL
Enrollment

156

Participants

Timeline

Start Date

April 10, 2019

Primary Completion Date

June 9, 2023

Study Completion Date

December 30, 2027

Conditions
Intracranial Aneurysm
Interventions
DEVICE

FRED, FRED Jr and FRED X

Subjects aged ≥ 18 requiring treatment for an unruptured or recanalized intracranial aneurysm

Trial Locations (1)

D-91054

Universitätsklinikum Erlangen, Erlangen

All Listed Sponsors
lead

Microvention-Terumo, Inc.

INDUSTRY

NCT03920358 - FRED/ FRED Jr/ FRED X Intracranial Aneurysm Treatment Study | Biotech Hunter | Biotech Hunter